Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ACELRX PHARMACEUTICALS INC | acrx20150821_8k.htm |
EXHIBIT 16.1 TO FORM 8-K
August 21, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01(a) of Form 8-K dated August 21, 2015, of AcelRx Pharmaceuticals, Inc. and are in agreement with the statements contained in the second, third, fourth and fifth paragraphs on page two therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP